Physician

Amir M. Agha, MD

According to 2025 Medicare claims, Amir Agha, MD (NPI: 1730144114) practices rheumatology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Anderson, SC. This provider's primary affiliated billing organization is FOOTHILLS RHEUMATOLOGY (NPI: 1073584769; TIN: 571076769) and primary practice location at 29621-1722.

Agha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 434 traditional Medicare patients, billed 143,612 HCPCS/CPT codes, and received $1,507,288 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,780 prescription claims across 752 beneficiaries totaling $2,071,348 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 77 records totaling $1,532. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.7M2015 Medicare payment: $1,425,674 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,841,595 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,952,471 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,478,659 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,719,608 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,675,961 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,595,772 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,243,128 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,757,308 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,507,288 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201575359,190$1,425,674
201677385,225$1,841,595
201771294,369$1,952,471
2018629138,270$2,478,659
2019596153,146$2,719,608
2020568157,554$2,675,961
2021541166,620$2,595,772
2022510175,944$2,243,128
2023454150,650$1,757,308
2024434143,612$1,507,288

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.3M2015 Drug cost: $1,412,590 (USD; Tot_Drug_Cst)2016 Drug cost: $1,847,738 (USD; Tot_Drug_Cst)2017 Drug cost: $2,267,676 (USD; Tot_Drug_Cst)2018 Drug cost: $1,911,109 (USD; Tot_Drug_Cst)2019 Drug cost: $1,841,028 (USD; Tot_Drug_Cst)2020 Drug cost: $2,081,580 (USD; Tot_Drug_Cst)2021 Drug cost: $2,097,170 (USD; Tot_Drug_Cst)2022 Drug cost: $2,136,445 (USD; Tot_Drug_Cst)2023 Drug cost: $2,067,340 (USD; Tot_Drug_Cst)2024 Drug cost: $2,071,348 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20158556,810$1,412,590
20168987,252$1,847,738
20178937,416$2,267,676
20188296,243$1,911,109
20197605,775$1,841,028
20207736,244$2,081,580
20217825,894$2,097,170
20227745,884$2,136,445
20237465,822$2,067,340
20247525,780$2,071,348

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4201,526$84
96413Administration of chemotherapy into vein, 1 hour or less100598$84
20610Aspiration and/or injection of fluid from large joint105169$42
36415Insertion of needle into vein for collection of blood sample100560$9
J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg113319$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept681,904$506,502
Humira PenAdalimumab311,008$257,560
Humira(Cf) PenAdalimumab28868$221,131
XeljanzTofacitinib Citrate33990$217,834
OtezlaApremilast18960$149,073

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.77$1,532Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amir M. Agha, MD?

Tedicare shows public-source Medicare data for Amir M. Agha, MD (NPI 1730144114), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amir M. Agha, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amir M. Agha, MD?

Amir M. Agha, MD is linked to FOOTHILLS RHEUMATOLOGY (billing NPI 1073584769) in the available physician profile data.

Does Amir M. Agha, MD have Open Payments data?

Amir M. Agha, MD has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.